SEC Filing Details
Document Details
Form
Filing Date
Apr 8, 2020
Document Date
Mar 31, 2020
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Nektar Therapeutics
Issuer
NEKTAR THERAPEUTICS
Filer
WILSON MARK ANDREW